Clinical Research Directory
Browse clinical research sites, groups, and studies.
S-33 SMR Shoulder HP Reverse Glenosphere
Sponsor: Limacorporate S.p.a
Summary
Study Design: Single arm, retrospective and prospective, single center, post-market clinical study Purpose:To demonstrate the safety and effectiveness of the SMR Reverse HP Shoulder System device for primary, fracture or revision total shoulder replacement out to 24 months. The eligible study population is the entire population that underwent a reverse shoulder arthroplasty performed with 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres between January 1, 2013 and January 1, 2020 at Wrightington Hospital (UK) in accordance with the indication for use of the product.
Official title: Clinical and Radiographic Outcomes of Reverse Shoulder Arthroplasty Performed With 36-mm CoCrMo vs 40-mm Cross-linked UHMWPE Glenospheres.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
205
Start Date
2022-10-17
Completion Date
2024-01-11
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Interventions
SMR shoulder arthroplasty
Data collection of population that underwent a reverse shoulder arthroplasty performed with SMR 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres
Locations (1)
Wrightington, Wigan and Leigh NHS Foundation Trust
Wigan, United Kingdom